NCT03640026View on ClinicalTrials.gov

Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Tacrolimus

Tacrolimus will be initiated at 0.1 mg/kg/day in two separate 12-hour oral doses (capsules) for 14 days.

Trial Locations (2)

Unknown

RECRUITING

Centre Hospitalier Départemental Vendée, La Roche-sur-Yon

RECRUITING

Centre Hospitalier Universitaire Nantes, Nantes

All Listed Sponsors
lead

Centre Hospitalier Departemental Vendee

OTHER